Article
Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents.
Clinical pharmacology and therapeutics - 1 Dec 1993
LLerena A, Herraíz A G, Cobaleda J, Johansson I, Dahl M L
Abstract excerpt
Debrisoquin and S-mephenytoin hydroxylation phenotypes were determined in 72 Spanish psychiatric patients treated with neuroleptic or antidepressant agents. One patient (1.4%) was classified as a poor metabolizer of S-mephenytoin. Between both neuroleptic- and antidepressant-treated patients, the...
Topics
- Adult
- Aged
- Antidepressive Agents
- Antipsychotic Agents
- Cytochrome P-450 CYP2D6
- Cytochrome P-450 Enzyme System
- Debrisoquin
- Female
- Genotype
- Humans
- Hydroxylation
- Male
- Mephenytoin
- Middle Aged
- Mixed Function Oxygenases
- Phenotype
- Polymorphism, Genetic
